Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Ping Mao

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
Inhibitory RNA molecules in immunotherapy for cancerChih-Ping Mao, T-C Wu
Journal of Biomedical Science|November 15, 2006
Immunotherapeutic strategies employing RNA interference technology for the control of cancersChih-Ping Mao, Chien-Fu Hung, T-C Wu
Oncoimmunology|January 23, 2015
Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasionChih-Ping Mao, Tc Wu, Kwon-Ho Song, et al.
Immunology|April 13, 2007
Immunological research using RNA interference technologyChih-Ping Mao, Yen-Yu Lin, Chien-Fu Hung, et al.
Human Gene Therapy|March 11, 2009
Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Vaccine|October 13, 2007
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Human Gene Therapy|December 28, 2012
Innovative DNA vaccine to break immune tolerance against tumor self-antigenTae Heung Kang, Chih-Ping Mao, Victor La, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Programmed self-assembly of peptide-major histocompatibility complex for antigen-specific immune modulationChih-Ping Mao, Shiwen Peng, Andrew Yang, et al.
The American Journal of Surgical Pathology|January 9, 2026
Crypt Dysplasia is a Risk Factor for the Development of High-Grade Dysplasia/Adenocarcinoma in Barrett EsophagusVikram Deshpande, Melissa Zhao, Azfar Neyaz, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
Inhibitory RNA molecules in immunotherapy for cancerChih-Ping Mao, T-C Wu
Journal of Biomedical Science|November 15, 2006
Immunotherapeutic strategies employing RNA interference technology for the control of cancersChih-Ping Mao, Chien-Fu Hung, T-C Wu
Oncoimmunology|January 23, 2015
Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasionChih-Ping Mao, Tc Wu, Kwon-Ho Song, et al.
Immunology|April 13, 2007
Immunological research using RNA interference technologyChih-Ping Mao, Yen-Yu Lin, Chien-Fu Hung, et al.
Human Gene Therapy|March 11, 2009
Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Vaccine|October 13, 2007
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Human Gene Therapy|December 28, 2012
Innovative DNA vaccine to break immune tolerance against tumor self-antigenTae Heung Kang, Chih-Ping Mao, Victor La, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Programmed self-assembly of peptide-major histocompatibility complex for antigen-specific immune modulationChih-Ping Mao, Shiwen Peng, Andrew Yang, et al.
The American Journal of Surgical Pathology|January 9, 2026
Crypt Dysplasia is a Risk Factor for the Development of High-Grade Dysplasia/Adenocarcinoma in Barrett EsophagusVikram Deshpande, Melissa Zhao, Azfar Neyaz, et al.
Pageof 3